Literature DB >> 19428556

Role of macrophages in tumour progression.

K S Siveen1, Girija Kuttan.   

Abstract

It is now becoming clear that the inflammatory cells that exist in the tumour microenvironment play an indispensable role in cancer progression. Tumour associated macrophages (TAMs) represent a prominent component of the mononuclear leukocyte population of solid tumours, which displays an ambivalent relationship with tumours. They originate in the circulation and are recruited to the tumour site by tumour-derived attractants such as chemokines and interact with the tumour cells and preferentially localize at the tumour-host tissue interface, in regions often associated with low oxygen tensions. The tumour microenvironment, including cytokines and hypoxia, regulates the localization and function of TAMs. Upon activated by cancer cells, the TAMs can release a vast diversity of growth factors, proteolytic enzymes, cytokines, and inflammatory mediators. Many of these factors are key agents in cancer metastasis. Substantial evidence suggests that TAMs can interact with cancer cells, modify the ECM, and promote cancer cell invasion and metastasis. Several natural products have shown ability to inhibit the production of proinflammatory cytokines and growth factors by TAMs. The presence of extensive TAM infiltration has been shown to correlate with cancer metastasis and poor prognosis in a variety of human carcinomas.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19428556     DOI: 10.1016/j.imlet.2009.02.011

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  143 in total

Review 1.  Up for Mischief? IL-17/Th17 in the tumour microenvironment.

Authors:  E Maniati; R Soper; T Hagemann
Journal:  Oncogene       Date:  2010-08-23       Impact factor: 9.867

2.  Cripto-1 modulates macrophage cytokine secretion and phagocytic activity via NF-κB signaling.

Authors:  Dong-mei Zhang; Yong-Li Bao; Chun-Lei Yu; Yi-meng Wang; Zhen-Bo Song
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

3.  Immunotherapy for Head and Neck Squamous Cell Carcinoma.

Authors:  Rebecca C Hoesli; Jeffrey S Moyer
Journal:  Curr Oral Health Rep       Date:  2016-03-12

4.  Deciphering the Key Features of Malignant Tumor Microenvironment for Anti-cancer Therapy.

Authors:  Bingxue Shang; Gaochuan Zhang; Yanyan Pan; Quansheng Zhou
Journal:  Cancer Microenviron       Date:  2012-05-17

Review 5.  Feasibility of immunotherapy for lymphangioleiomyomatosis.

Authors:  Michele Carbone
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

Review 6.  Promising systemic immunotherapies in head and neck squamous cell carcinoma.

Authors:  Neil Gildener-Leapman; Robert L Ferris; Julie E Bauman
Journal:  Oral Oncol       Date:  2013-10-11       Impact factor: 5.337

7.  Expression of monocyte chemotactic protein-1/CCL2 in gastric cancer and its relationship with tumor hypoxia.

Authors:  Lei-Lei Tao; Shu-Jing Shi; Long-Bang Chen; Gui-Chun Huang
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

8.  Hypoxia-Inducible Factor α Subunits Regulate Tie2-Expressing Macrophages That Influence Tumor Oxygen and Perfusion in Murine Breast Cancer.

Authors:  Kayla J Steinberger; Mary A Forget; Andrey A Bobko; Nicole E Mihalik; Marieta Gencheva; Julie M Roda; Sara L Cole; Xiaokui Mo; E Hannah Hoblitzell; Randall Evans; Amy C Gross; Leni Moldovan; Clay B Marsh; Valery V Khramstov; Timothy D Eubank
Journal:  J Immunol       Date:  2020-09-16       Impact factor: 5.422

Review 9.  Targeting cellular and molecular drivers of head and neck squamous cell carcinoma: current options and emerging perspectives.

Authors:  Simonetta Ausoni; Paolo Boscolo-Rizzo; Bhuvanesh Singh; Maria Cristina Da Mosto; Giacomo Spinato; Giancarlo Tirelli; Roberto Spinato; Giuseppe Azzarello
Journal:  Cancer Metastasis Rev       Date:  2016-09       Impact factor: 9.264

10.  Progressive growth of a murine T cell lymphoma alters population kinetics and cell viability of macrophages in a tumor-bearing host.

Authors:  Pramod K Gautam; Babu N Maurya; Sanjay Kumar; Praveen Deepak; Sanjay Kumar; Munendra S Tomar; Arbind Acharya
Journal:  Tumour Biol       Date:  2012-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.